Terao, Ryo http://orcid.org/0000-0001-6182-4343
Obata, Ryo http://orcid.org/0000-0002-1762-0797
Okubo, Atsushi
Aoki, Shuichiro
Azuma, Keiko
Ahmed, Tazbir http://orcid.org/0000-0001-5839-9876
Inoda, Satoru http://orcid.org/0000-0003-4577-8169
Hashimoto, Yuto
Takahashi, Ryota
Yoshida, Hana
Misawa, Manami
Takahashi, Hironori
Takahashi, Hidenori http://orcid.org/0000-0001-5331-4730
Article History
Received: 16 January 2023
Revised: 5 March 2023
Accepted: 14 March 2023
First Online: 31 March 2023
Declarations
:
: This study involves human participants and was approved by the Institutional Board of Jichi Medical University Hospital (Ethics approval number: CU22-R003).
: Ryo Obata received honoraria for speaking/consulting from Santen, Bayer, Novartis, Chugai, Senju, and Boehringer Ingelheim.